IPM Brief – Issue 1 | The Last Mile Starts Here
By Denis Horgan
IPM Brief – Issue 1 | The Last Mile Starts Here
Cancer Sequencing Becomes the Operating System of Precision Oncology
Personalised Cancer Vaccines Show Longer-Term Staying Power
Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease
A new Lp(a) threshold could reshape cardiovascular risk assessment
The next cardiometabolic battleground is ultra-processed food
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Explore by disease area
Cardiology
Mapping prevention, diagnostics and access pathways for cardiovascular care.
Cardiometabolic
Tracking risk, prevention and access in metabolic and vascular health.
Eye Disease
Following diagnostics, treatment access and equity in vision care.
Infectious disease
Tracking diagnostics, resistance, prevention and access across infection pathways.
Neurology
Mapping early diagnosis, biomarkers and access in brain health.
Oncology
Following testing, treatment access and equity across cancer pathways.
Alerts
See all →
Personalised Cancer Vaccines Show Longer-Term Staying Power
China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone
High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority
Lenacapavir Turns HIV Prevention Into an Access Stress Test
WHO’s New AMR Plan Makes Stewardship and Access a Single Test
Can cortisol become the next target in type 2 diabetes?
An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer
Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test
Ebola PHEIC Turns Outbreak Control Into a Preparedness Test
Signals
See all →
Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease
A new Lp(a) threshold could reshape cardiovascular risk assessment
Cancer Sequencing Becomes the Operating System of Precision Oncology
ASCO 2026 showed how comprehensive genomic solutions are moving from research support to the practical backbone of cancer detection, profiling, monitoring and treatment matching.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
By subscribing, you agree to receive updates from IPM Alliance. You can unsubscribe at any time. For more information, please see our Privacy Policy.
